- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02318056
The Burn Glove Trial - Hand Burn Dressing Pilot
The Burn Glove Trial-A Randomized Controlled Trial of Dressings for Partial Thickness Hand Burns
Specific Aim 1: To determine if one of three burn dressings provides a less painful healing experience for partial thickness hand.
Specific Aim 2: To evaluate if one of three dressings provides greater functionality during and after healing of partial thickness hand burns.
Specific Aim 3: To determine if one of three burn dressings promotes aesthetically superior healing results for partial thickness hand burns.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Various products are on the market and available for use on partial thickness burns to the hand/s. Our current institutional standard of care is to use Xeroform Gauze (Coviden, Mansfield, MA) and Bacitracin Ointment (Fougera, Melville, NY) to promote a moist antibacterial healing environment with the ability to monitor the healing progress daily. However, silver (AG) based dressings that employ nanocrystalline technology with hydrofiber (Aquacel AG burn; ConvaTec, Princeton, NJ) or soft silicone foam (Mepilex AG ; Molnlycke Health Care, Dunstable, United Kingdom) have been well accepted as alternative dressing solutions. These dressings have longer interval times between changes, leading to a reported increase in patient comfort, diminished skin shearing/stripping, and rapid re-epithelialization.
Given the anatomic intricacies, partial thickness burns to the hand present a challenge in dressing selection. Recently, ConvaTec unveiled the Aquacel AG Burn Glove for use on partial thickness hand burns. In line with this idea, our institution has now begun to fashion a novel burn glove out of Mepilex Transfer AG with good success. To date there are no known studies that compare Xeroform/Bacitracin, Aquacel AG burn glove or Mepilex Transfer AG dressing. The goal of this study is to compare these three burn dressings used to treat partial-thickness hand burns and their impact on pain, function, and aesthetic outcomes. We will also explore psychosocial issues related to hand burn dressing changes.
Study Type
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Illinois
-
Springfield, Illinois, United States, 62794-9640
- Southern Illinois University School of Medicine
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients presenting at Memorial Medical or Southern Illinois University (SIU) Health Care
- Patients with partial-thickness burn injuries to the dorsum and/or palm of the hand/s that exceeds ½% total body surface area (TBSA) for at least one hand.
- < 10% TBSA 2nd and 3rd degree burn injuries
- Initial clinical presentation < 5 days post burn injury
Exclusion Criteria:
- < ½ % TBSA involving the hand
- > 10%TBSA burn injuries
- > 60 years of age
- < 8 years of age
- Patients (or parents of minors) without cognitive capacity to comprehend informed consent
- Presentation > 5 days post-burn injury event
- Pregnant women
- Full thickness/3rd degree burns to the dorsal and/or palmer hand/s
- Exposed vital structures (tendons, nerves, bone, vessels)
- Uncontrolled Type II Diabetes
- Type I Diabetes
- History of Chronic Obstructive Pulmonary Disease
- Have a known allergy to silver products
- Signs of infection on initial clinical presentation (presence of purulent drainage, significant cellulitis, and/or fever)
- Smoke/inhalation injuries requiring ventilation
- Critically ill patients requiring intensive care
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Aquacel® Ag Burn Glove
Application of Aquacel® Ag Burn Glove burn dressing
|
burn dressing
Other Names:
|
Active Comparator: Mepilex® Transfer Ag
Application of Mepilex® Transfer Ag burn dressing
|
burn dressing
Other Names:
|
Active Comparator: Xeroform®/Bacitracin®
Application of Xeroform® burn dressing and Bacitracin® topical antibiotic
|
antibiotic burn dressing
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
pain
Time Frame: baseline to 6 months post-burn injury
|
pain as measured by the Patient and Provider Scar Assessment Scale
|
baseline to 6 months post-burn injury
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
pain
Time Frame: baseline to 6 months post-burn injury
|
pain as measured by the Michigan Hand Outcomes Questionnaire (MHQ)
|
baseline to 6 months post-burn injury
|
pain
Time Frame: baseline to 6 months post-burn injury
|
pain as measured by the Disabilities of the Arm, Shoulder and Hand Scale, Quick (QuickDASH)
|
baseline to 6 months post-burn injury
|
functionality
Time Frame: baseline to 6 months post-burn injury
|
functionality as measured by the Michigan Hand Outcomes Questionnaire (MHQ)
|
baseline to 6 months post-burn injury
|
functionality
Time Frame: baseline to 6 months post-burn injury
|
functionality as measured by the Disabilities of the Arm, Shoulder and Hand Scale, Quick (QuickDASH)
|
baseline to 6 months post-burn injury
|
aesthetic appearance
Time Frame: baseline to 6 months post-burn injury
|
scar formation and aesthetic appearance measured using the Vancouver Scar Scale
|
baseline to 6 months post-burn injury
|
aesthetic appearance
Time Frame: baseline to 6 months post-burn injury
|
scar formation and aesthetic appearance measured using the the Patient and Provider Scar Assessment Scale
|
baseline to 6 months post-burn injury
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
quality of life
Time Frame: baseline to 6 months post-burn injury
|
quality of life measured by the psychosocial scales: Burn Specific Health Scale (BSHS)
|
baseline to 6 months post-burn injury
|
resilience
Time Frame: baseline to 6 months post-burn injury
|
resilience measured by the Connor-Davidson Resilience Scale (CD-RISC)
|
baseline to 6 months post-burn injury
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Nada N Berry, MD, Southern Illinois University
Publications and helpful links
General Publications
- Bowler PG, Jones SA, Walker M, Parsons D. Microbicidal properties of a silver-containing hydrofiber dressing against a variety of burn wound pathogens. J Burn Care Rehabil. 2004 Mar-Apr;25(2):192-6. doi: 10.1097/01.bcr.0000112331.72232.1b.
- Atiyeh BS, Costagliola M, Hayek SN, Dibo SA. Effect of silver on burn wound infection control and healing: review of the literature. Burns. 2007 Mar;33(2):139-48. doi: 10.1016/j.burns.2006.06.010. Epub 2006 Nov 29.
- Wasiak J, Cleland H, Campbell F. Dressings for superficial and partial thickness burns. Cochrane Database Syst Rev. 2008 Oct 8;(4):CD002106. doi: 10.1002/14651858.CD002106.pub3.
- Robson MC, Smith DJ Jr, VanderZee AJ, Roberts L. Making the burned hand functional. Clin Plast Surg. 1992 Jul;19(3):663-71.
- Kamolz LP, Kitzinger HB, Karle B, Frey M. The treatment of hand burns. Burns. 2009 May;35(3):327-37. doi: 10.1016/j.burns.2008.08.004. Epub 2008 Oct 25.
- Walburn J, Vedhara K, Hankins M, Rixon L, Weinman J. Psychological stress and wound healing in humans: a systematic review and meta-analysis. J Psychosom Res. 2009 Sep;67(3):253-71. doi: 10.1016/j.jpsychores.2009.04.002. Epub 2009 Jul 2.
- Hollinger MA. Toxicological aspects of topical silver pharmaceuticals. Crit Rev Toxicol. 1996 May;26(3):255-60. doi: 10.3109/10408449609012524.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- ABR-SIUSOM-14-002
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Burns
-
American Scitech InternationalJohnson & JohnsonUnknownBurns | Electric BurnsUnited States
-
MediWound LtdUnknownBurns, Upper Extremity | Burns, Lower ExtremitySlovakia
-
Singapore General HospitalUnknownAcute Thermal BurnsSingapore
-
RenovaCare, IncActive, not recruitingBurns | Burns Second Degree | Burns Deep Second DegreeUnited States
-
MediWound LtdCompletedThermal BurnsUnited States, Israel, Belgium, Czechia, Georgia, Germany, Italy, Romania
-
Sun Yat-sen UniversityCompleted
-
MediWound LtdActive, not recruitingThermal BurnsUnited States, United Kingdom, Spain, Georgia, Belgium, Poland, Germany, Hungary, India, Italy, Netherlands, Romania, Slovakia, Ukraine
-
Virginia Commonwealth UniversityNot yet recruiting
-
The Hong Kong Polytechnic UniversityCompleted
-
St. Justine's HospitalRecruiting
Clinical Trials on Aquacel® Ag Burn Glove
-
University Hospital, GhentCompletedBurn Wounds - Partial Thickness (2nd Degree)Belgium
-
ConvaTec Inc.CompletedLeg UlcersUnited Kingdom
-
Kansas City Heart Rhythm InstituteCompletedWounds and Injuries | InfectionsUnited States
-
Golden Jubilee National HospitalConvaTec Inc.Withdrawn
-
ConvaTec Inc.Bristol-Myers SquibbCompletedSplit-Thickness Donor Sites.United States
-
Dr Angela OatesConvaTec Inc.CompletedDiabetes | Chronic Foot WoundsUnited Kingdom
-
ConvaTec Inc.NAMSACompletedDiabetic Foot | Venous Leg UlcerGermany, Colombia, United Kingdom
-
ConvaTec Inc.CompletedLeg UlcerDenmark, France, Germany, Poland, United Kingdom
-
National Taiwan University HospitalUnknownUlcer | Head and Neck Cancer | Head and Neck Neoplasms | WoundsTaiwan
-
Molnlycke Health Care ABCompleted